Changes in plasma bone GLA protein during treatment of bone disease
Leonard J. Deftos(University of California San Diego), Paul A. Price(Eastern Michigan University), Jacqueline G. Parthemore(University of California San Diego)
Cited by 164
Related Papers
Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia
|New England Journal of Medicine|1980|720
New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.
|Journal of Clinical Investigation|1980|660
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
|New England Journal of Medicine|1986|484
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
|Cancer Epidemiology Biomarkers & Prevention|2006|364
The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
|Journal of Clinical Investigation|1977|296